Pembrolizumab-Associated Optic Neuritis With an Unusual Manifestation of Monocular Optic Disc Edema

J Neuroophthalmol. 2024 Jun 1;44(2):e246-e248. doi: 10.1097/WNO.0000000000001798. Epub 2023 Jan 4.

Authors

Roxana Teodorescu¹, Henry Liu, Alfredo A Sadun

Affiliation

¹ Doheny Eye Institute (RT, HL, AAS), Los Angeles, California; and Department of Ophthalmology (AAS), David Geffen School of Medicine at University of California, Los Angeles, California.

PMID: 36728538
DOI: 10.1097/WNO.0000000000001798

No abstract available

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Antineoplastic Agents, Immunological / adverse effects
Humans
Magnetic Resonance Imaging
Optic Neuritis* / chemically induced
Optic Neuritis* / diagnosis
Optic Neuritis* / drug therapy
Papilledema* / chemically induced
Papilledema* / diagnosis
Papilledema* / etiology
Tomography, Optical Coherence / methods
Visual Acuity

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab